|Articles|July 1, 2001
- Applied Clinical Trials-07-01-2001
Affairs of State
As FDA monitors more international clinical trials, new policies aim to address differences in national approaches to such issues as placebos and protocols.
Advertisement
Articles in this issue
almost 25 years ago
Letters to the Editoralmost 25 years ago
Conference Reportsalmost 25 years ago
Pen-Based Computingalmost 25 years ago
Some Do--Some Watch Over Those Who Doalmost 25 years ago
Communication Skills for Monitors—A Vital Training Opportunityalmost 25 years ago
ACT 101 Human Safety in Clinical ResearchAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention
3
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
4
SCOPE X: What Real-Time Patient Data Is Doing to ClinOps Efficiency
5